Your browser doesn't support javascript.
loading
Response to: 'Glucocorticoid withdrawal in lupus: to do or not to do?' by Acharya.
Mathian, Alexis; Pha, Micheline; Amoura, Zahir.
Afiliação
  • Mathian A; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France, Paris, France.
  • Pha M; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France, Paris, France.
  • Amoura Z; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France, Paris, France zahir.amoura@aphp.fr.
Ann Rheum Dis ; 81(3): e45, 2022 03.
Article em En | MEDLINE | ID: mdl-32241796

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucocorticoides Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glucocorticoides Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article